10-KT Filing

YUBO INTERNATIONAL BIOTECH LTD CIK: 895464 FY 2020

Filing Information

Form Type	10-KT
Accession Number	`0001640334-21-001022`
Period End Date	20201231
Filing Date	20210423
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	yubo-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 36 Cash Flow Statement 51 Stockholders Equity 16

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$1.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$4.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Notes payable and accrued interest payable to related parties	`NotesPayable`	-	USD	Point-in-time
Notes payable and accrued interest payable to related parties	`NotesPayable`	$1.41M	USD	Point-in-time
Notes payable and accrued interest payable to related parties	`NotesPayable`	$1.28M	USD	Point-in-time
Accounts payable	`AccountsPayableOtherCurrent`	$342.00K	USD	Point-in-time
Accounts payable	`AccountsPayableOtherCurrent`	$353.00K	USD	Point-in-time
Accounts payable	`AccountsPayableOtherCurrent`	$7.43K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$41.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$40.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.67M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.43K	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $.01 per share, 5,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $.01 per share, 5,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $.01 per share, 5,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$27.29M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$28.72M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$27.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-29.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.84M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-7.43K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.52M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	-	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$1.00K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$4.00K	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	Annual
REVENUES	`Revenues`	-	USD	3 Qtrs
REVENUES	`Revenues`	-	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$57.72K	USD	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$48.00K	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$29.00K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-48.00K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-57.72K	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-29.00K	USD	Annual
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	Annual
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	Annual
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	$-191.00K	USD	3 Qtrs
Gain from settlement of accounts payable and due to related party	`GainFromSettlementOfAccountsPayableAndDueToRelatedParty`	-	USD	Annual
Gain from settlement of accounts payable and due to related party	`GainFromSettlementOfAccountsPayableAndDueToRelatedParty`	$-167.00K	USD	3 Qtrs
Gain from settlement of accounts payable and due to related party	`GainFromSettlementOfAccountsPayableAndDueToRelatedParty`	-	USD	Annual
Interest expense	`InterestExpense`	$105.00K	USD	Annual
Interest expense	`InterestExpense`	$53.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$100.00K	USD	Annual
Other income (expense) - net	`OtherNonoperatingIncomeExpense`	$305.00K	USD	3 Qtrs
Other income (expense) - net	`OtherNonoperatingIncomeExpense`	$-105.00K	USD	Annual
Other income (expense) - net	`OtherNonoperatingIncomeExpense`	$-100.00K	USD	Annual
NET INCOME (LOSS) BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$247.28K	USD	3 Qtrs
NET INCOME (LOSS) BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-134.00K	USD	Annual
NET INCOME (LOSS) BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-148.00K	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
NET INCOME (LOSS)	`NetIncomeLoss`	$-148.00K	USD	Annual
NET INCOME (LOSS)	`NetIncomeLoss`	$-134.00K	USD	Annual
NET INCOME (LOSS)	`NetIncomeLoss`	$247.28K	USD	3 Qtrs
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.93M	shares	3 Qtrs
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.18M	shares	Annual
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.18M	shares	Annual
NET INCOME (LOSS) PER CLASS A AND CLASS B COMMON SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	Annual
NET INCOME (LOSS) PER CLASS A AND CLASS B COMMON SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	Annual
NET INCOME (LOSS) PER CLASS A AND CLASS B COMMON SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$0.01	USD	3 Qtrs

Cash Flow Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-148.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-134.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$247.28K	USD	3 Qtrs
Company expenses paid by Platinum International Biotech Co. Ltd (Cayman Islands) and affiliates	`CompanyExpensesPaidByPlatinumInternational`	$22.30K	USD	3 Qtrs
Company expenses paid by Platinum International Biotech Co. Ltd (Cayman Islands) and affiliates	`CompanyExpensesPaidByPlatinumInternational`	-	USD	Annual
Company expenses paid by Platinum International Biotech Co. Ltd (Cayman Islands) and affiliates	`CompanyExpensesPaidByPlatinumInternational`	-	USD	Annual
Gain from debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain from debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain from debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-191.00K	USD	3 Qtrs
Gain from debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$191.00K	USD	Point-in-time
Gain from settlement of accounts payable	`GainLossRelatedToLitigationSettlement`	-	USD	Annual
Gain from settlement of accounts payable	`GainLossRelatedToLitigationSettlement`	-	USD	Annual
Gain from settlement of accounts payable	`GainLossRelatedToLitigationSettlement`	$-167.00K	USD	3 Qtrs
Due to related parties	`IncreaseDecreaseInDueToRelatedParties`	-	USD	Annual
Due to related parties	`IncreaseDecreaseInDueToRelatedParties`	$9.00K	USD	3 Qtrs
Due to related parties	`IncreaseDecreaseInDueToRelatedParties`	-	USD	Annual
Accrued interest payable to related parties	`IncreaseDecreaseInDueFromRelatedParties`	-	USD	Annual
Accrued interest payable to related parties	`IncreaseDecreaseInDueFromRelatedParties`	$53.00K	USD	3 Qtrs
Accrued interest payable to related parties	`IncreaseDecreaseInDueFromRelatedParties`	-	USD	Annual
Accounts payable and accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$116.00K	USD	Annual
Accounts payable and accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$15.43K	USD	3 Qtrs
Accounts payable and accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$112.00K	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-11.00K	USD	3 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-22.00K	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-32.00K	USD	Annual
Proceeds received from notes payable to related parties-	`ProceedsFromRelatedPartyDebt`	$19.00K	USD	Annual
Proceeds received from notes payable to related parties-	`ProceedsFromRelatedPartyDebt`	$10.00K	USD	3 Qtrs
Proceeds received from notes payable to related parties-	`ProceedsFromRelatedPartyDebt`	$34.00K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$19.00K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$34.00K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$10.00K	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.00K	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.00K	USD	Annual
NET (DECREASE) INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.00K	USD	Annual
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.00K	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$2.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	Annual
Cash paid for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Conversion of notes payable and accrued interest into Class A common shares	`ConversionOfNotesPayableAndAccruedInterestIntoClassACommonShares`	$1.47M	USD	3 Qtrs
Payment of accounts payable and accrued expenses by Activist Investing LLC pursuant to Stock Purchase Agreement dated June 30, 2020	`PaymentOfAccountsPayableAndAccruedExpensesByActivistInvestingLlcPursuantToStockPurchaseAgreementDatedJune302020`	$49.00K	USD	3 Qtrs
Company expenses paid by Platinum International Biotech Co. Ltd. (Cayman Islands) and affiliates	`CompanyExpensesPaidByPlatinumInternationalBiotechCoLtdCaymanIslandsAndAffiliates`	$22.30K	USD	3 Qtrs

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Balance, amount	`StockholdersEquity`	$-7.43K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.52M	USD	Point-in-time
Net income/loss	`NetIncomeLoss`	$-148.00K	USD	Annual
Net income/loss	`NetIncomeLoss`	$-134.00K	USD	Annual
Net income/loss	`NetIncomeLoss`	$247.28K	USD	3 Qtrs
Payment of accounts payable and accrued expenses by Activist Investing LLC on July 2, 2020 pursuant to Stock Purchase Agreement dated June 30, 2020	`PaymentOfAccountsPayableAndAccruedExpensesByActivistInvestingLlcOnJuly22020PursuantToStockPurchaseAgreementDatedJune302020`	$37.00K	USD	3 Qtrs
Conversion of notes payable and Accrued interest to Class A shares on September 23, 2020, amount	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.47M	USD	3 Qtrs
Payment of accrued expenses ($3,000) and due to related parties ($9,000) by Activist Investing LLC in the three months ended November 30, 2020 pursuant to Stock Purchase Agreement dated June 30, 2020	`PaymentOfAccruedExpenses3000AndDueToRelatedParties9000ByActivistInvestingLlcInTheThreeMonthsEndedNovember302020PursuantToStockPurchaseAgreementDatedJune302020`	$12.00K	USD	3 Qtrs
Company expenses paid by Platinum International Biotech Co. Ltd. (Cayman Islands) and affiliates	`CompanyExpensesPaidByPlatinumInternationalBiotechCoLtdCaymanIslandsAndAffiliates`	$22.30K	USD	3 Qtrs
Adjustments, amount	`AdjustmentsAmount`	-	USD	3 Qtrs
Balance, amount	`StockholdersEquity`	$-7.43K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.52M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.